Wright Medical Completes Cartiva Acquisition

By Julie A. Vetalice

Wright Medical completed its previously announced acquisition of Cartiva, developer of the PMA-approved Synthetic Cartilage Implant to treat arthritis at the base of the great toe.

As noted in mid-3Q18, total price for the transaction was US $435MM in cash. Wright will provide updated full-year 2018 guidance, including the impact of this purchase, in its 3Q18 earnings call on November 7.

Sources: Wright Medical Group N.V.; ORTHOWORLD Inc.

Product Labels: Traditional Soft Tissue Repair

Tags: M&A